- 如果您对该产品感兴趣的话，可以
- 产品名称：Anti-SH2D3A抗体
- 产品型号：SH2结构域蛋白3A抗体
- 产品展商：KALANG
- 产品文档：无相关文档
- 发布时间：2018-08-04
- 在线询价
简单介绍
Anti-SH2D3A抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-SH2D3A抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
产品描述
Rabbit Anti-SH2D3A
Cat. Number:
Anti-SH2D3A抗体KL-6158R
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
SH2D3A is a 576 amino acid protein that is thought to play a role in JNK activation. SH2D3A interacts with p130 Cas and is found at low levels in fetal kidney, fetal lung, placenta, ***** pancreas, kidney and lung. Subject toAnti-SH2D3A抗体 post-translational phosphorylation on multiple tyrosine residues, SH2D3A contains one Src homology 2 (SH2) domain. SH2 domains bind to tyrosine-phosphorylated regions of target proteins, frequently linking activated growth factors to putative signal transduction proteins. The gene encoding SH2D3A maps to human chromosome 19, which consists of over 63 million bases, houses approximately 1,400 genes and is recognized for having the greatest gene density of the human chromosomes. It is the genetic home for a number of immunoglobulin (Ig) superfamily members, including the killer cell and leukocyte Ig-like receptors, a number of ICAMs, the CEACAM and PSG families and Fc receptors (FcRs).
Also known as:
Novel SH2 containing protein 1; Anti-SH2D3A抗体NSP1; SH2 domain containing 3A; SH2 domain containing protein 3A; SH23A_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Pig, Cow, Sheep, .
●
Immunogen: KLH conjugated Anti-SH2D3A抗体synthetic peptide derived from human NSP1/SH2D3A.
●
Predicted Molecular Weight: 63kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-SH2D3A抗体
Optimal working dilutions must be determined by the end user.
